M. d’Yvoire

发表

Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients.

J. Ménard, G. Chatellier, L. Vaur, 1998, American journal of hypertension.

Pharmacocinétique / pharmacodynamie clinique des antibiotiques

Roger W. Jelliffe, M. d’Yvoire, X. Barbaut, 2000 .

Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps.

George Loizou, Harvey J Clewell, Hugh A Barton, 2008, Regulatory toxicology and pharmacology : RTP.

Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin.

M. d’Yvoire, P. Tulkens, F. Van Bambeke, 1998, The Journal of antimicrobial chemotherapy.

INDUCTION OF LABOUR WITH MIFEPRISTONE AFTER INTRAUTERINE FETAL DEATH

D. Cabrol, E. Baulieu, M. d’Yvoire, 1985, The Lancet.

Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data.

B. Bannwarth, M. d’Yvoire, T. Schaeverbeke, 1997, Revue du rhumatisme.

Differential Effects of a Missed Dose of Trandolapril and Enalapril on Blood Pressure Control in Hypertensive Patients

P. Meredith, L. Vaur, C. Dutrey-Dupagne, 1995, Journal of cardiovascular pharmacology.

Physiologically-based Kinetic Modelling (PBK Modelling): Meeting the 3Rs Agenda

Ursula Gundert-Remy, Martin Spendiff, Alan Boobis, 2007, Alternatives to laboratory animals : ATLA.

Pharmacokinetics of Thiocolchicoside in Humans Using a Specific Radioimmunoassay

M. d’Yvoire, O. Chappey, J. Scherrmann, 1995, Therapeutic drug monitoring.

Single‐dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers

P. Chrétien, J. Tillement, M. d’Yvoire, 1994, Biopharmaceutics & drug disposition.